Skip to main content
Clinical Trials/NCT04898491
NCT04898491
Recruiting
N/A

Validity and Reliability Study of the Pain Indicator Behavior Scale Adapted to Measure Pain in Critically Ill Patients With Acquired Brain Damage, Non-communicative and With an Artificial Airway (ESCID-DC).

Candelas Lopez Lopez1 site in 1 country300 target enrollmentJune 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain
Sponsor
Candelas Lopez Lopez
Enrollment
300
Locations
1
Primary Endpoint
To assess the construct validity and the reliability
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.

Detailed Description

Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation. The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre. Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
June 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Candelas Lopez Lopez
Responsible Party
Sponsor Investigator
Principal Investigator

Candelas Lopez Lopez

RN, MSc, PhD

Hospital Universitario 12 de Octubre

Eligibility Criteria

Inclusion Criteria

  • Age equal to or greater than 18 years.
  • Inability to communicate verbally or motor.
  • Have a artificial airway.
  • Informed consent of the family member or representative of the patient.

Exclusion Criteria

  • Previous pathology of cognitive impairment.
  • Previous brain injury.
  • Previous psychiatric disorder.
  • Previous dementia.
  • Previous chronic substance abuse.
  • Previous chronic diabetics.
  • Previous spinal cord injury.
  • Previous severe polyneuropathy (diagnosed or suspected).
  • Confirmed diagnosis of brain death.
  • Continuous infusion of muscle relaxants and / or barbiturate coma.

Outcomes

Primary Outcomes

To assess the construct validity and the reliability

Time Frame: 30 months

Number of patients with Brain Damage, non-communicative and artificial airway that manifest pain behaviors included in the Pain Indicator Behavior Scale-Brain Damage

Secondary Outcomes

  • To analyze the scale under different levels of consciousness(30 months)
  • To assess pain from different procedures with ESCID-DC scale(30 months)
  • To assess pain from different procedures with NCS-R scale(30 months)
  • To analyze the scale under different etiology of brain damage(30 months)
  • To analyze the scale under different degrees of sedation(30 months)

Study Sites (1)

Loading locations...

Similar Trials